Section I:Food Regulations and Standards——Session 3:Nutrition Policy |
2026-03-14 09:00-12:00 BFA,Dong Yu Grand Ballroom A |
| |
| 2026-03-14 09:00-09:30 National Nutrition Policies |
| 2026-03-14 09:30-10:00 Dietary Guidelines for Chronic Diseases Series |
| 2026-03-14 10:00-10:30 Key Tasks and Future Plans of the National Nutrition Plan for 2026Zhihong Wang Research Fellow,Deputy Director of，Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-14 10:30-11:00 Nutrition and Health Standards and Their Formulation DirectionZhang Bing Researcher,Deputy Director of the Institute of Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-14 11:00-11:30 Agricultural and Food Nutrition Policies and Standards |
| 2026-03-14 11:30-12:00 Roundtable Meeting:Healthy Food High-Quality Development Led by Nutrition Policies and StandardsModerator: |
Section II:New Technologies and New Products——Session 2:Efficacy and Evidence-Based Applications of Ergothioneine |
2026-03-14 09:00-12:00 Dongyu,Hesheng room(Wanquan Ballroom 1/3) |
Moderator：He Tao,Deputy Director,Key Laboratory of Food Nutrition and Health Evaluation Technology,State Administration for Market Regulation |
| 2026-03-14 09:00-09:20 Synthetic biology of ergothioneine in edible mushrooms and its anti-aging effects |
| 2026-03-14 09:20-09:40 Dr.Ergo® Ergothioneine:Re-establishing the Value of the 5th-Generation Smart Antioxidants Based on Clinical Evidence |
| 2026-03-14 09:40-10:00 Synergistic Inhibition of Acrolein Activity by Ergothioneine and GABA:In Vitro and In Vivo Studies |
| 2026-03-14 10:00-10:20 Redefining Dietary Supplements with Evidence-Based Science and Human Clinical Evidence |
| 2026-03-14 10:20-10:40 The protective effect of ergothioneine on oxidative damage of nerve cells |
| 2026-03-14 10:40-11:00 Ergothioneine:Efficacy Research and Regulatory Status |
| 2026-03-14 11:00-11:55 Roundtable Meeting：The Development Path of Ergothioneine in ChinaModerator: |
| 2026-03-14 11:55-12:00 |
Section II:New Technologies and New Products——Session 3:New Breakthroughs in HMOs Precision Nutrition and Its Diversified Population Applications |
2026-03-14 08:30-11:40 Dongyu,Yiyong room(Wanquan Ballroom 1/3) |
Moderators: |
| 2026-03-14 08:30-08:50 Chinese HMOs Profile:Research and Application |
| 2026-03-14 08:50-09:10 Regulatory Effects of HMOs on Glucose and Lipid Metabolism Disorders in Adults |
| 2026-03-14 09:10-09:30 The trends of regulatory management of HMOs |
| 2026-03-14 09:30-09:50 The Potential Application Value of HMOs in the Field of Healthy Aging |
| 2026-03-14 09:50-10:10 Research on the Effect of Human Milk Oligosaccharides on Brain Development |
| 2026-03-14 10:10-10:30 From the Wisdom of Breast Milk to Clinical Promise:HMOs and Probiotics in Synergy to Protect Preterm Infant Gut Health |
| 2026-03-14 10:30-10:50 The Effects of Multiple Human Milk Oligosaccharides and HMO-Based Combinations on Infant/Toddler Health and Neurocognitive Development:Evidence-Based Research and Future Innovation Pathways |
| 2026-03-14 10:50-11:10 Unlocking the Health Code of HMOs:Clinical Research Exploration and Practice by Synaura Bio |
| 2026-03-14 11:10-11:30 Global Trends in HMO Research and Applications |
| 2026-03-14 11:30-12:00 Roundtable Meeting：Risks of Biosynthetic Human Milk Oligosaccharides (HMOs) Applied in the Production of Infant and Toddler Formula Milk PowderModerator: |
Section VI:Probiotics,Prebiotics and Postbiotics——Postbiotics Session |
2026-03-14 09:00-11:00 BFA,Dong Yu Grand Ballroom C |
| |
| 2026-03-14 09:00-09:20 A Novel Fermented Oat with Postbiotic Effect:Design Strategies and Scientific Basis |
| 2026-03-14 09:20-09:40 Post LB Postbiotics and the Intestinal Barrier:Current Scientific Evidence and Novel Insights |
| 2026-03-14 09:40-10:00 Postbiotics Along the Gut–Brain Axis:LAC‑Living+ as a Clinically Evidenced Driver of New Growth in Emotional Well‑Being |
| 2026-03-14 10:00-10:20 New Randomized Controlled Trial Findings of Gastric-Derived Lactobacillus johnsonii LJ88 for Gastric Health |
| 2026-03-14 10:20-11:00 |
Innovation Forum：Amino Acids and Health |
2026-03-14 09:00-12:00 BFA,Dong Yu Grand Ballroom D |
Moderators:Liu Aidong,Research Fellow & Director,National Institute for Nutrition and Health,Chinese Center for Disease Control and Prevention |
Research on the Efficacy and Applications of Amino Acids |
| 2026-03-14 09:00-09:10 |
| 2026-03-14 09:10-09:30 Application of Amino Acids in Foods for Special Dietary Uses and Standard Formulation |
| 2026-03-14 09:30-09:50 Amino Acid Metabolism:The Overlooked Role of Gut Microbiota in it |
| 2026-03-14 09:50-10:10 Research and Application of L-Theanine |
| 2026-03-14 10:10-10:30 Gut Microbiota-Derived Aromatic Amino Acid Metabolites Prevent Obesity Through Intestinal Immunity |
| 2026-03-14 10:30-10:50 Glutamate：From a Safe Nutrient to a Tool for Salt Reduction |
| 2026-03-14 10:50-11:10 Current Status of China's Food-Grade Amino Acid Industry and Outlook for the 15th Five-Year Plan |
| 2026-03-14 11:10-11:55 Roundtable MeetingModerator: |
| 2026-03-14 11:55-12:00 |
Innovation Forum：Allulose |
2026-03-14 09:00-11:50 BFA,Dong Yu Grand Ballroom B |
Moderator:Li Fengqin,Research Fellow,China National Center for Food Safety Risk Assessment |
| 2026-03-14 09:00-09:20 A New Perspective on Sweetness:Molecular Characteristics,Functional Properties,and Food Applications of Sugar Substitutes |
| 2026-03-14 09:20-09:40 Synthetic Biology-Driven Novel Green Synthesis Pathway of D-Psicose |
| 2026-03-14 09:40-10:00 Enzymatic Synthesis of Allulose:Full-Chain Innovation from Efficient Biomanufacturing to Food Applications |
| 2026-03-14 10:00-10:20 Clinical Evidence for Metabolomic Analysis of D-Psicose in Humans and Evaluation of Its Health Benefits |
| 2026-03-14 10:20-10:40 Sweetness Preserved,Health Enhanced:Construction and Challenges of Functional Sugar Application Matrix |
| 2026-03-14 10:40-11:45 Roundtable Meeting：Industrial Track and Development of Functional Sugars in ChinaModerator: |
| 2026-03-14 11:45-11:50 |
Innovation Forum：Real Human Scientific Testing for Health Foods – A Data-Driven Innovation Solution |
2026-03-14 09:00-11:15 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Supported by:Yiwi Testing & Evaluation (Shanghai) Co.,Ltd.;Hainan Huayan collagen Technology Co.,Ltd., |
Clinical Trial Launch Ceremony and Product Launch for the "Nannochloropsis Oculata and Turmeric Beverage Combination" |
| 2026-03-14 09:15-09:35 Imaging Diagnosis and Clinical Management of Pulmonary NodulesWang Song,Chief Physician,Longhua Hospital Shanghai University of Traditional Chinese Medicine |
| 2026-03-14 09:35-09:55 Research on the Synergistic Effects of Nutrient Combinations |
| 2026-03-14 09:55-10:15 Standardized Evaluation of Food-as-Medicine Products:Clinical Trial Exploration in a Pulmonary Nodule Population |
| 2026-03-14 10:15-10:35 Cross-Border Integration of Pharmaceutical and Food Industries： Innovative Paths and Practical Applications — Collagen Cyclic Dipeptides |
| 2026-03-14 10:35-10:55 From "Experience-Driven"to "Evidence-Driven":Building a New Hanfang Brand from a Global Perspective |
| 2026-03-14 10:55-11:15 Evidence-Based Assessment of Fresh Collagen for Oral Beauty Therapy |
| 2026-03-14 11:15-11:35 Complete a true closed-loop validation through real-world consumer scenarios |
FHE2026 Healthy Food Youth Innovation Competition（Final） |
2026-03-14 09:00-17:00 BFA,Oriental Theatre |